News
2h
France 24 on MSNEurope on brink of endemic dengue and chikungunya as mosquitoes move northClimate change is pushing disease-carrying tiger mosquitoes deeper into Europe, raising the risk that once-tropical viruses ...
6h
Agence France-Presse on MSNDengue, chikungunya may soon be endemic in Europe: researchThe feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...
A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.
Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty answers questions about the ...
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths. About 80,000 Ixchiq doses have ...
Explore more
U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...
The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
The FDA and CDC recommended the pause while the government looks into possible side effects. Also: RFK Jr. raises eyebrows after swimming with his grandkids in a contaminated creek; President Donald ...
Federal health officials are advising Americans aged 60 and older to avoid the chikungunya vaccine Ixchiq amid an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results